Large-scale data analysis (Figure 5D–F) and our immunocytochemical analysis (Figure 6A–D) also revealed a strong relationship between the significantly increased expression of both SERPINB2 itself and constituents in its related signaling pathways and metastatic progression or recurrence in breast, colorectal and liver cancers. The gene discussed is SERPINB2; the disease is liver cancer.